Ashley Bateman

Ashley Bateman is a policy reform writer for The Heartland Institute and contributor to The Federalist as well as a blog writer for Ascension Press. Her work has been featured in The Washington Times, The Daily Caller, The New York Post, The American Thinker and numerous other publications. She previously worked as an adjunct scholar for The Lexington Institute and as editor, writer and photographer for The Warner Weekly, a publication for the American military community in Bamberg, Germany. Ashley earned a BA in literature from the College of William and Mary.
Advertismentspot_img

Latest News

Pressure Mounts to End COVID-19 National Emergency Declaration

“It cannot be justified by fears of a hypothetical recurrence of some more severe infection at some unknown hypothetical point in the future. We just cannot operate public health policy this way. "

Lower Cost Biologics Face Obstacles, Says Biosimilars Group

Generic drug and biosimilar manufacturers opposed to the drug-price provisions of the Inflation Reduction Act (IRA) continue to push cost-saving reforms.

CDC’s LGBT Youth Resources Promotes ‘Q Chat Space’

The Centers for Disease Control and Prevention has set up an “LGBT Youth Resources” webpage in which it promotes a live group chat site for teens to learn more about changing their biological sex, transgender activism, drag, and divergent sexual relationships.

Push is On to Promote Cheaper Biosimilars

To boost the acceptance of cheaper biosimilars, a drug industry trade group is taking a more aggressive approach in reaching out to pharmacists, patients, and their doctors.

Republican Bills Promote Hospital Competition in Health Reform Effort

The bills are in line with the findings of a poll in April of voters, that found regardless of whether they identify as Republican, Democrat, or Independent, they do not want their health care fundamentally changed but prefer improvements that would lead to better access, expand coverage and lower cost.

FDA to Put ‘Grandfathered’ Drugs Through the Regulatory Wringer

“The Trump administration terminated UDI because it provided nothing in the way of added drug safety but raised their prices substantially."

Republicans Issue Health Reform Wish List

Their solutions, announced on June 1, include an expansion of telehealth beyond the public health emergency declaration, the elimination of waste, fraud, and abuse by rewarding states who crack down on improper payments, and the expansion of technologies that would improve patient well-being.

Private Organization Launches Alternative Vaccine Injury Reporting System

The Vaccine Adverse Events Reporting System (VAERS), jointly run by the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) has been challenged as an “outdated and unreliable” database for vaccine injuries, especially since the emergency use authorization of COVID-19 vaccines

Oregon Officials Agree to Physician-Assisted Suicide for Non-Residents

“The state just went into negotiations. That’s going against what the people voted on in 1994 and 1997. The people of Oregon were voting on a law that would only apply to the state of Oregon.”

Canadian Patients Share Health Care Wait Woes

“Sadly, there are hundreds of thousands of stories to tell so we would never be able to capture them all."

Ashley Bateman

Ashley Bateman is a policy reform writer for The Heartland Institute and contributor to The Federalist as well as a blog writer for Ascension Press. Her work has been featured in The Washington Times, The Daily Caller, The New York Post, The American Thinker and numerous other publications. She previously worked as an adjunct scholar for The Lexington Institute and as editor, writer and photographer for The Warner Weekly, a publication for the American military community in Bamberg, Germany. Ashley earned a BA in literature from the College of William and Mary.

Most Popular